Are muscle relaxers safe during the 3rd trimester of pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safety of Muscle Relaxants in the 3rd Trimester of Pregnancy

Muscle relaxants should generally be avoided during the third trimester of pregnancy due to potential risks to the fetus, with limited safety data available to support their use.

Types of Muscle Relaxants and Their Safety Profiles

Pharmacological Muscle Relaxants

  • Cyclobenzaprine and other pharmacological muscle relaxants have limited safety data during pregnancy, with some evidence suggesting increased risk of birth defects with periconceptional exposure 1
  • A recent study found associations between cyclobenzaprine use during early pregnancy and several birth defects including cleft palate, anorectal abnormalities, and cardiac defects, though these findings are preliminary and require confirmation 1
  • Most muscle relaxants lack comprehensive safety data for use during the third trimester specifically, requiring cautious clinical decision-making 2

Beta-Blockers (Sometimes Used for Muscle Relaxation)

  • If muscle relaxation is needed, certain beta-blockers may be safer options in the third trimester compared to dedicated muscle relaxants 3
  • Beta-blockers with selective β1 properties are theoretically preferable as they may interfere less with peripheral vasodilation and uterine relaxation 3
  • Metoprolol is preferred over atenolol during pregnancy as it has a lower incidence of fetal growth retardation 3
  • Atenolol is classified as a category D agent by the FDA and should be avoided 3

Risks and Concerns in the Third Trimester

  • The third trimester presents unique physiological challenges that may increase sensitivity to muscle relaxants 2
  • Potential risks include:
    • Premature labor or uterine contractions 4
    • Fetal respiratory depression if used close to delivery 2
    • Altered maternal hemodynamics that could affect placental perfusion 2

Non-Pharmacological Alternatives

  • Physical therapy and appropriate exercise programs are recommended as first-line approaches for musculoskeletal pain during pregnancy 3
  • Relaxation massage has shown positive effects throughout pregnancy for healthy women without complications, including reduced back and leg pain 5
  • Stationary cycling, swimming, or aquafit are safer activities associated with less risk of falling or physical contact 3
  • Proper body mechanics and ergonomic adjustments can help reduce musculoskeletal strain 3

Special Considerations

  • Women with certain conditions like active preterm labor, severe pre-eclampsia, or intrauterine growth restriction should avoid both muscle relaxants and strenuous physical activity 3
  • For women with constipation (which can cause discomfort mistaken for muscle tension), safer treatments include dietary fiber, lactulose, and polyethylene glycol-based laxatives 3

Clinical Approach

  • Assess the severity and cause of muscle pain to determine if pharmacological intervention is truly necessary 3
  • Consider non-pharmacological approaches first, including physical therapy, massage, and appropriate exercise 3, 5
  • If medication is deemed necessary, consult with both obstetric and maternal-fetal medicine specialists to weigh risks and benefits 3
  • Document the clinical reasoning for using muscle relaxants if alternatives have failed and the benefit clearly outweighs potential risks 2

Warning Signs

  • If muscle relaxants are used, patients should immediately stop and seek medical attention if they experience:
    • Regular and painful uterine contractions 3
    • Vaginal bleeding 3
    • Persistent dizziness or faintness that does not resolve with rest 3
    • Severe chest pain or shortness of breath 3

In conclusion, while limited data exists specifically on muscle relaxants in the third trimester, the potential risks generally outweigh benefits when safer alternatives are available. Non-pharmacological approaches should be prioritized, and any pharmacological intervention should be made with careful consideration of maternal and fetal risks.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.